BioXcel Therapeutics terminates four officers, appoints Samir Saleem president amid bankruptcy wind-down

BioXcel Therapeutics announced on October 30, 2026 the termination of four officers and the appointment of Samir Saleem as president and secretary. The leadership changes occur in the context of a court-supervised bankruptcy sale and the planned wind-down of the company's affairs, now operating under ticker BTAIQ.

Detected & updated continuously · Source: Nebula